• Japanese
  • Korean
  • Chinese
Cover Image

Biotechnology in India

Abstract

This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors - Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for this market. The report profiles 102 companies including many key and niche players such as Advanced Enzymes Technologies Ltd., Ajeet Seeds Ltd., Anthem BioSciences Pvt. Ltd., Bharat Biotech International Limited, Bharat Serums and Vaccines Ltd., Biocon Limited, Syngene International Limited, Dr. Reddy's Laboratories Ltd., Ecron Acunova, Eli Lilly and Company (India) Pvt. Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Indian Immunologicals Ltd., Jubilant Life Sciences Limited, Krishidhan Seeds Private Limited, Lambda Therapeutic Research Ltd., Mahyco, Max Neeman, Monsanto, Novo Nordisk India Pvt. Ltd., Novozymes South Asia Pvt. Ltd., Nuziveedu Seeds Pvt. Ltd., Ocimum Biosolutions Ltd., Panacea Biotec Ltd., Piramal Healthcare Limited, Quintiles India, Rasi Seeds (P) Ltd., Reliance Life Sciences, Serum Institute of India Ltd., Shantha Biotechnics Limited, SIRO Clinpharm, Strand Life Sciences, Veeda Clinical Research Limited, and Vimta Labs Limited. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc. (GIA) is a reputed publisher of off-the-shelf market research. Recognized as one of the most consistently accurate forecasting company in the world, GIA currently serves more than 9,500 companies from 36 countries worldwide. The company was founded in 1987, initially recognized globally as a research boutique specializing in the medical industry. Over the past 25 years, the company expanded its coverage and now publishes extensively upon more than 180 major industries.

Our experienced team is dedicated to world-class research and analysis. We attribute our success to our people, their commitment and work culture.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definition and Scope of Study
    • Bio-Pharmaceuticals
    • Bio-Agriculture
    • Bio-Industrial
    • Bioinformatics
    • Bio-Services

II. AN INDIAN MARKET REPORT

1. OUTLOOK

  • Recession and Foreign Exchange Rate Decelerate Industry Growth
  • Industry Emerges Strong Following Recession
  • Brighter Prospects Ahead for the Indian Biotech Industry

2. INDUSTRY OVERVIEW

  • SWOT Analysis
  • Diversity - Key Strength for the Industry
  • Major Sectors in the Indian Biotechnology Industry
  • Government Support for Biotech Innovation - A Boost for the Industry
  • Challenges Ahead
  • Concerted Efforts are On to Find a Way Out
  • Major Industry-Specific Advantages of the Indian Biopharma Sector
  • Competition
    • Table 1: Leading Biotech Companies in India by Revenues: 2009-10 (includes corresponding Graph/Chart)
    • Table 2: Leading Domestic Biotech Companies in India by Revenues: 2009-10 (includes corresponding Graph/Chart)
  • Exports - A Major Market for Indian Biotech Industry
    • Table 3: Export Revenues of Indian Biotech Industry by Sector (2008-09 & 2009-10): Export Value in US$ Million for Bio-Pharma, Bio-Services, Bio-Agri, Bio-Industrial, and Bioinformatics (includes corresponding Graph/Chart)
    • Table 4: Biotechnology Industry Export Revenues as a Percentage Share of Total Segment Revenues: 2009-10 (includes corresponding Graph/Chart)
  • Analysis by Region
  • Western Region's Domination Continues in Revenue Terms, Mumbai Moves to the Top
    • Table 5: Leading States in the Indian Biotech Industry by Revenues: 2009-10 (includes corresponding Graph/Chart)
    • Table 6: Leading Cities In the Indian Biotech Industry by Revenues: 2009-10 (includes corresponding Graph/Chart)
  • Karnataka Embarks on Further Growth Plans; Other Regions Join the League

3. ISSUES AND TRENDS

  • Government Support to the Biotechnology Sector Surges
  • Recognizing the Importance of Right Educational System
  • Need for a Streamlined Regulatory Process Continues
  • Angel Funding - Still Eluding the Sector
  • More Countries Look to India for Outsourcing
  • China and India - Competing for Biotech Investments

4. BIO-PHARMACEUTICALS IN INDIA

    • Table 7: Indian Bio-Pharmaceuticals Market by Segment (2011): Percentage Share Breakdown for Vaccines, Diagnostics, Therapeutics, and Others (includes corresponding Graph/Chart)
  • Competitive Landscape of the Biopharma Sector
    • Table 8: Leading BioPharma Companies in India by Revenues: 2009-10 (includes corresponding Graph/Chart)
  • Market Analysis by Segment
  • Vaccines
    • Vaccines to Spearhead Growth in the Indian BioPharma Market
    • Demand for Vaccines to Surge
    • India to Emerge as a Global Hub for Vaccines
  • Diagnostics
    • India Diagnostics Market - An Overview
    • Table 9: Leading Players in the Indian Diagnostics Market by Revenues: Market Share Breakdown of Revenues for Tulip, TransAsia Biomedical, Bayer, Span Diagnostics, and Others (2010) (includes corresponding Graph/Chart)
    • Indian Diagnostics Industry - Stifled with High Competition
    • Diagnostic Centers Expand Test Menu to Beat Competition
  • Bio-Therapeutics - Going Strong
    • Overseas Giants Dominate the Insulin Market
    • Plasma Proteins - A Potential Growth Area
    • mAbs Gain Prominence in the Biopharma Industry
  • Market Trends
  • Climbing Up the Value Chain
  • Domestic Market to Provide Impetus to Bio-Pharma Industry Growth
  • Biosimilars to Offer Tremendous Prospects for Indian Players
    • Table 10: Indian Market for Biosimilars by Drug Class (2009): Revenues for Insulin, EPO, Interferon, Streptokinase, and G-CSF (includes corresponding Graph/Chart)
  • Biopharmaceutical Pipeline Growth Continues
    • r-DNA Biopharmaceuticals Cleared for Pre-Clinical Studies: 2009-10
  • Indian Firms Embrace Strategic Partnerships to Enter Biotech Industry
  • Indian Biopharma Market Luring Overseas Players
  • Indian Pharma Companies on a Co-Development Spree
  • Vaccines Remain the Center of Focus in Indian BioPharma
  • Brighter Prospects Ahead in Original Drug Development
  • Myriad Factors Drive Growth in the Indian BioPharma Sector
  • Pharma Companies Shift Focus to BioPharma

5. BIO-AGRICULTURE IN INDIA

  • Indian Bio-Agriculture Industry - An Overview
  • Select Biotech Crops in India Under Field Trials: 2008
  • Transgenic Crops Cleared for Limited Field Trials: 2009-10
  • India - A Leading Adopter of Biotech Crops Worldwide
  • Bio-Agri Treads On A Fast-Track Growth Path
  • Public and Private Sector Participation in Bio-Agri Research
  • Bt Cotton - A Major Success in India
  • Indian Farmers Increasingly Embrace Bollgard II Cotton
  • Monsanto And Mahyco to Battle Out Pink Bollworm Resistance in Bollgard - I
  • Move to Commercialize Bt Brinjal Draws Major Controversy
  • Government Retreats, Imposes Moratorium on Launch of Bt Brinjal
  • Moratorium on Bt Brinjal Launch, A Setback to the Industry?
  • Establishment of BRAI Also Faces the Heat of Opponents
  • Stark Criticism Compels India to Establish Transparent Administration of Biotech Procedures
  • Bio-Diesel Market - Still in Infancy
  • Bio-Fertilizers and Bio-Pesticides Market - An Overview
  • Competitive Scenario in the Bio-Agri Sector
    • Table 11: Leading Bio-Agriculture Companies in India by Revenues: 2009-10 (includes corresponding Graph/Chart)

6. BIO-INDUSTRIAL SECTOR IN INDIA

  • Indian Bio-Industrial Sector - Fairly Concentrated
    • Table 12: Leading Players in the Indian Bio-Industrial Sector (2009-10): Market Share as Percentage of Revenues for Novozymes, Advanced Enzyme Technologies, and Others (includes corresponding Graph/Chart)

7. BIOINFORMATICS

  • Indian BioInformatics Market Posts Sluggish Growth

8. BIO-SERVICES

  • Indian Bio-Services Market Bustling with Activity
  • India - A Growing Hub for Clinical Trials
  • Competitive Scenario
    • Table 13: Leading Biotechnology Services Companies in India By Revenues (2009-10) (includes corresponding Graph/Chart)

9. REGULATORY SETUP

  • Regulatory Evolution in the Country
  • Department of Biotechnology
  • Public Sector Undertakings under the DBT
  • Autonomous Institutions operating under the DBT
  • Roles and Responsibilities of DBT
  • Various Committees Operating Under the DBT and MoEF
    • GEAC or the Genetic Engineering Approval Committee
    • Review Committee on Genetic Manipulation
    • Institutional Bio-Safety Committee
    • Recombinant DNA Advisory Committee
    • Central Drugs Standard Control Organization
      • Select Acts, guidelines and regulations that govern the biotechnology industry in India
      • Agencies Supporting and Financing Biotechnology Research in India
  • New Regulatory Framework on the Horizon
  • National Biotechnology Strategy

10. INDUSTRY INFRASTRUCTURE

  • Biotech and Science Parks in the Country
  • Select Biotech and Science Parks in India
  • Major Research Institutes in India
  • Select Key Research Institutes in India
  • Autonomous Biotechnology Institutes in India

11. BIOTECHNOLOGY - AN OVERVIEW

  • Biotechnology
  • A Peek into the History of Biotechnology
  • Select Major Applications of Biotechnology
  • Medicine
    • Pharmacogenomics
    • Biopharmaceuticals
    • Genetic Testing
    • Gene Therapy
    • Cloning
  • Agriculture
  • Bioremediation and Biodegradation

12. PRODUCT APPROVALS/LAUNCHES

  • Panacea Biotec to Introduce PacliALL
  • Gene Logic Rolls Out ASCENTA System Version 4.0
  • Bharat Biotech International Unveils HNVAC™ H1N1 Swine Flu Vaccine
  • Strand Scientific Intelligence Introduces Avadis NGS
  • Dr Reddy's Rolls Out Generic Darbepoetin Alfa Drug, Cresp®
  • BD Biosciences and ReaMetrix Unveil New Reagents
  • Serum Institute of India Rolls Out Nasovac H1N1 Vacccine in India
  • Ocimum Biosolutions Introduces Biotracker™
  • Novo Nordisk Launches Antidiabetic Drug, Victoza in India
  • Cadila Healthcare Launches Vaxiflu-S
  • Ocimum Biosolutions Introduces qRT-PCR Services
  • Wockhardt Rolls Out Biotechnology Products
  • Intas Biopharma Launches Borviz in India
  • Bharat Biotech International Unveils COMVAC5® Vaccine

13. RECENT INDUSTRY ACTIVITY

  • Piramal Healthcare to Change Name to Piramal Enterprises
  • Bharat Biotech Commences Phase III Clinical Trial with THR-100
  • Bayer Teams Up with Zydus for Joint Venture in India
  • Qiagen Establishes Qiagen India
  • Ecron Acunova Expands Capacity at Mangalore Clinical Research Center
  • IndianOil Inks MOU with LanzaTech
  • Dow AgroSciences and GVK Biosciences Discover New Compound
  • Ecron Acunova Establishes Joint Venture CRO in Thailand
  • Praj Industries Enters into Partnership with Qteros
  • Mavens Biotech to Venture into Biotech Education
  • Aurobindo Pharma to Divest Stake in Its Chinese Subsidiary
  • Abbott Acquires Formulation Business of Piramal Healthcare
  • Evolvence India Life Sciences Takes Over Stake in Fermenta Biotech
  • Strides Arcolab to Take Over 70% Stake in Inbiopro Solutions
  • Rallis Acquires Majority Stake in Metahelix
  • Ocimum Secures US$8 Million Funding for Future Growth
  • Dr. Reddy's to Purchase US Penicillin Facility and Product Rights from GSK
  • Life Technologies to Take Over Labindia
  • Biocon Enters into Strategic Global Agreement with Pfizer
  • Intas Biopharma to Ink Out-Licensing Deal with Japanese Firm
  • Biocon Limited and CMI Enter into Immunology Research Collaboration
  • Biocon Signs Contract with Teleradiology Solutions
  • Jubilant Organosys Changes Name to Jubilant Life Sciences
  • Jubilant Inks CRAMS Deal with a US Firm
  • MSCCC and Strand Life Sciences Ink MOU for Translational Cancer Research
  • Lohmann Animal Health Enters into Joint Venture with Suguna
  • International Stem Cell Inks a Distribution Agreement with Sristi Biosciences
  • BioServe Biotechnologies Receives NABL Accreditation for GMO Testing
  • Indian Immunologicals to Develop Oral Cervical Cancer Vaccine
  • Piramal Healthcare to Take Over the Assets of BioSyntech
  • Ocimum Biosolutions to Offer BioIT Consulting Services
  • Zydus Obtains DCGI Clearance for Initiating Phase I Trials on Zyog1
  • Krishidhan Establishes Subsidiary in Europe
  • Biocon Limited Inks Supply Deal with Optimer Pharmaceuticals
  • Australia to Grant Research Funding to India
  • Ocimum Biosolutions and Jivan Biologics Enter into Partnership
  • Stempeutics Completes Phase I/II Study of Stemepucel-CLI Stem Cell Product
  • Ranbaxy Enters into Alliance with Pfenex
  • Syngene Collaborates with Endo Pharmaceuticals
  • Panacea Biotech Obtains Financial Assistance from DBT for Vaccine Development
  • M. D. Anderson Cancer Center Selects Biotracker™ of Ocimum Biosolutions
  • GVK Biosciences Establishes New Clinical Pharmacology Unit
  • Delta Embedded Solutions to merge with Bio-Analytical Technologies
  • Clingene Seeks Alliance with SIRO Clinpharm
  • Biocon Investments in Malaysian Biotech Market
  • Ranbaxy to Foray into Vaccines Market through Acquisition of Biovel's Assets
  • Clinigene International Deploys PheedIt Solution of SAS
  • Sanofi Takes Over Shantha Biotech
  • Bioseed Research India Inks Strategic Partnership Agreement with KeyGene
  • PRAJ Partners with Novozymes
  • Mylan sells stake in Concord Biotech
  • Vibha Seeds Sets Up Seed Facility in Andhra Pradesh
  • Bayer Cropscience Inks Research Cooperation Agreement with GVK Biosciences
  • Millipore Acquires Outstanding Stake of its Joint Venture in India
  • Avesthagen Forms Joint Venture with Limagrain
  • Indus Biotech Receives HIV Controller Status for IND02 from FDA
  • Bharat Biotech Commences Construction at Konark Knowledge Park in Orissa
  • International Biotech Park to Forge International Alliances
  • Merck Acquires Bangalore Genei
  • Bharat Biotech Secures International Patents for Lysostaphin
  • Genzyme Inks MoU with NIPER for Offering Biotechnology Fellowships
  • Biocon Enters into Agreement with Amylin Pharmaceuticals
  • WHO and DCGI Direct Serum Institute of India to Focus on H1N1 Vaccine
  • Acoris Research Enters into Strategic Partnership with c-LEcta
  • Serum Institute of India to Expedite Vaccine Development
  • Sanofi Aventis Acquires Shantha Biotechnics
  • Biocon Inks a Strategic Collaboration Agreement with Mylan
  • Lonza to Invest in Genome Valley for Two Major Projects
  • Bio-Rad Laboratories Integrates DiaMed Scientific Technologies in India
  • Syngene Enters into Alliance with DuPont Crop Protection
  • Emami Biotech Limited and Calcutta Tramways Company Ink MoU
  • TCG Lifesciences and Pfizer Extend Master Services Agreement
  • Biological E Commences Operations at New Campus
  • Syngene Enters into Partnership with Sapient
  • Intas Biopharmaceuticals Inks MoU with Government of Gujarat
  • Emami's Bio-Diesel Obtains SGS Certification
  • Ocimum Biosolutions Enters into Partnership with NuGEN

14. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER

  • Biocon Collaborates with Abraxis to Introduce Abraxane in India
  • Intas Biopharmaceuticals Takes Over BPD
  • Bharat Biotech Completes Phase I/II Clinical Trials for 116E Oral Rotavirus Vaccine
  • Intas Biopharmaceuticals to Commercialize Gefitinib in India
  • Avesthagen Inks LoI with ShigaMediX
  • Ranbaxy Signs Collaborative Research Agreement with DBT
  • Veeda Establishes Global Oncology Contract Research Organization
  • Avesthagen Signs Framework Agreement with DuBiotech
  • Biocon Buys Majority Stake in German Company
  • Monsanto India to Sell Butachlor & Alachlor Businesses to Sinochem International
  • Biocon Signs Strategic Partnership Agreement with IATRICa
  • Intas Pharmaceuticals to Sell Biotechnology Products in GCC

15. FOCUS ON SELECT LEADING PLAYERS

  • Advanced Enzymes Technologies Ltd.
  • Ajeet Seeds Ltd.
  • Anthem BioSciences Pvt. Ltd.
  • Bharat Biotech International Limited
  • Bharat Serums and Vaccines Ltd.
  • Biocon Limited
  • Syngene International Limited
  • Dr. Reddy's Laboratories Ltd
  • Ecron Acunova
  • Eli Lilly and Company (India) Pvt. Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • Indian Immunologicals Ltd.
  • Jubilant Life Sciences Limited
  • Krishidhan Seeds Private Limited
  • Lambda Therapeutic Research Ltd.
  • Mahyco
  • Max Neeman
  • Monsanto
  • Novo Nordisk India Pvt. Ltd.
  • Novozymes South Asia Pvt. Ltd.
  • Nuziveedu Seeds Pvt. Ltd.
  • Ocimum Biosolutions Ltd.
  • Panacea Biotec Ltd.
  • Piramal Healthcare Limited
  • Quintiles India
  • Rasi Seeds (P) Ltd.
  • Reliance Life Sciences
  • Serum Institute of India Ltd.
  • Shantha Biotechnics Limited
  • SIRO Clinpharm
  • Strand Life Sciences
  • Veeda Clinical Research Limited
  • Vimta Labs Limited

16. MARKET ANALYTICS

    • Table 14: Indian Recent Past, Current & Future Analysis for Biotechnology Industry by Sector - Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 15: Indian Historic Review for Biotechnology Industry by Sector- Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 16: Indian 15-Year Perspective for Biotechnology Industry by Sector - Percentage Breakdown of Dollar Sales for Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services Markets for Years 2003, 2011 and 2017 (includes corresponding Graph/Chart)
    • Table 17: Indian Recent Past, Current & Future Analysis for Bio-Pharmaceuticals by Segment - Vaccines, Diagnostics, Therapeutics, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
    • Table 18: Indian Historic Review for Bio-Pharmaceuticals by Segment - Vaccines, Diagnostics, Therapeutics, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
    • Table 19: Indian 15-Year Perspective for Bio-Pharmaceuticals by Segment - Percentage Breakdown of Dollar Sales for Vaccines, Diagnostics, Therapeutics, and Others Markets for Years 2003, 2011 and 2017 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Show More
Pricing